A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...
Puma Biotechnology announced the grant of an inducement award to a November new hire, as required under Nasdaq Listing Rule ...
When Julie Durbin was undergoing cancer treatment, she was always cold. She would bring a cardigan, a sweater that opens in ...
Hosted on MSN8h
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLCMerck MRK announced that the FDA has granted breakthrough therapy designation (BTD) to sacituzumab tirumotecan (sac-TMT) for ...
A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...
Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the ...
Linda D’Addario, a cancer survivor, now mentors others through Cancer Hope Network, a program now available at five area ...
Schad, a compassionate soul and dedicated community member, passed away on Friday, November 29, 2024, at the age of 50 at CHP ...
GlobalData on MSN1d
Novartis and Olema expand alliance with $250m to boost breast cancer trialsOlema Oncology plans to start a Phase III trial studying palazestrant with a CDK4/6 inhibitor from Novartis in mid-2025.
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, ...
Olema Oncology has announced that it has entered into a clinical trial collaboration and supply agreement with Novartis to ...
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback